SERTM2

Last updated

SERTM2, also known as the Serine Rich And Transmembrane Domain Containing 2, is a protein which in humans is encoded by the SERTM2 gene. The SERTM2 protein is a transmembrane protein located in the intracellular membrane and active in membrane-bound organelles. [1] [2] SERTM2 expression has been linked to metastatic prostate tumors, prostate carcinomas and renal cell carcinomas. [3] [4]

Contents

Gene

SERTM2 labelled at location Xq23 SERTM2 Chromosome Label.jpg
SERTM2 labelled at location Xq23

The SERTM2 gene in humans is located on the positive strand of the X chromosome (Xq23), spanning 10,755 base pairs. [5] The SERTM2 gene has three total exons. There is one known transcript or isoform that spans 4,612 base pairs. [6]

Aliases

SERTM2 is also known as:

Protein

Predicted tertiary structure prediction of the SERTM2 protein in humans, Microcaecilia unicolor, alligators, and wombats. Blue = high confidence, yellow = low confidence. Made using the AlphaFold Protein Structure Database. HasSERTM2Protein.png
Predicted tertiary structure prediction of the SERTM2 protein in humans, Microcaecilia unicolor, alligators, and wombats. Blue = high confidence, yellow = low confidence. Made using the AlphaFold Protein Structure Database.

The SERTM2 protein is 90 amino acids long. This protein has a predicted molecular weight of 10 kDa and an isoelectric point of 6. [11] [12] The human SERTM2 protein structure contains two topological domains: extracellular and cytoplasmic. [13] These domains are connected by a transmembrane domain within a confirmed alpha helix. [8] [9] [10] [12] The human protein contains a disordered region at the tail of the protein. [12] Despite having serine-rich in its common name, the protein was not found to have abundance of serine or any other amino acid when compared to other human proteins. [11]

Post-translational modifications

Diagram of human SERTM2 protein highlighting its transmembrane domain. The N-terminus is extracellular, and the C-terminus is intracellular. Made using Protter. Problem Set 4 2022.docx (1).jpg
Diagram of human SERTM2 protein highlighting its transmembrane domain. The N-terminus is extracellular, and the C-terminus is intracellular. Made using Protter.

The human SERTM2 protein has one confirmed post-translational modification at the 11th position. [6] The asparagine at that position undergoes N-linked glycosylation, or the attachment of an oligosaccharide to a nitrogen atom on the asparagine side chain. [15]

Expression

RNA-sequencing and human tissue profiling has found that SERTM2 is expressed primarily in the endometrium prostate, and liver of humans at moderate level. [6] SERTM2 is found to be upregulated in cardiac progenitor cells compared to mesoderm cells and in fetal cells versus adult heart tissue using RNA-sequencing data. [7] Using knockout and overexpression experiments, it was found that both the knockout and overexpression of SERTM2 results in low cardiomyocyte yield, suggesting that expression must be carefully regulated during cellular differentiation for normal cardiac development to occur and resulted in the nickname CARDEL (Cardiac Development Long non-coding RNA). [7]

Homologs and evolution

The human SERTM2 has no paralogs. SERTM2 orthologs are found in mammals, birds, reptiles, amphibians, and some fish. [13] The earliest known SERTM2 gene appeared 462 million years ago in the catshark, a cartilaginous fish. The gene is hard to find in fish, with only two other known appearances in the tiger barb and the Chinese sucker fish, two bony fish. SERTM2 became more established in amphibians 352 million years ago, and its orthologs are found throughout modern reptiles, birds, mammals, and primates. [12]

Table 1:Human serine-rich and transmembrane-domain containing 2 (SERTM2) gene orthologs. Orthologs are sorted first by date of divergence from the human gene, then by similarity to the human sequence. [12]

Common NameScientific NameAccession NumberTaxonomical GroupSequence Length (amino acids)Date of Divergence

(MYA)

% identical
PrimataHumanHomo sapiens NP_001341402.1 Primates 90-100
Ring-tailed lemur Lemur catta XP_045393689.1 Primates 907493
Beluga whale Delphinapterus leucas XP_030615360.1 Cetacea 909492
Mouse Mus musculus NP_001341422.1 Rodentia 898791
Big brown bat Eptesicus fuscus XP_054573025.1 Chiroptera 909481
Common wombat Vombatus ursinus XP_027691215.1 Marsupial 9016081
Aves Blue tit Cyanistes caeruleus XP_023773484.1 Aves 9131976
Chicken Gallus gallus XP_046795767.1 Aves 9231973
Reptilia Alligator Alligator mississippiensis XP_059588794.1 Crocodilia 9231979
Burmese python Python bivittatus XP_025020345.1 Squamata 9231975
Softshell turtle Pelodiscus sinensis XP_025033828.1 Testudines 9231960
Amphibians Microcaecilia unicolor Microcaecilia unicolor XP_030065343.1 Gymnophiona 9135268
Two-lined caecilians Rhinatrema bivittatum XP_029463498.1 Gymnophiona 9335267
Common frog Rana temporaria XP_040179805.1 Anura 9235270
Fish/Sharks Tiger barb Puntigrus tetrazona XP_043094501.1 Osteichthyes 10342924
Chinese sucker fish Myxocyprinus asiaticus XP_051542736.1 Osteichthyes 10842921
Catshark Scyliorhinus canicula XP_038632174.1 Chondrichthyes 8946242

Clinical significance

Metastatic tumors in the prostate have been shown to have 3-fold more expression of SERTM2 than primary tumors, suggesting that overexpression of SERTM2 may be linked to the metastatic nature of prostate tumors. [3] SERTM2 overexpression has been observed in tumor microenvironment of androgen receptor pathway-positive adenocarcinoma of the prostate (ARPC). [4] In comparison to ARPC, SERTM2 expression is lower in the tumor microenvironment of neuroendocrine prostate carcinomas (NEPC), a more severe type of prostate cancer. [4]

References

  1. Alliance of Genome Resources. "SERTM2" . Retrieved 28 September 2023.
  2. Watanabe, Ryuta; Miura, Noriyoshi; Kurata, Mie; Kitazawa, Riko; Kikugawa, Tadahiko; Saika, Takashi (January 2023). "Spatial Gene Expression Analysis Reveals Characteristic Gene Expression Patterns of De Novo Neuroendocrine Prostate Cancer Coexisting with Androgen Receptor Pathway Prostate Cancer". International Journal of Molecular Sciences. 24 (10): 8955. doi: 10.3390/ijms24108955 . ISSN   1422-0067. PMC   10219300 . PMID   37240308.
  3. 1 2 Chandran, Uma R.; Ma, Changqing; Dhir, Rajiv; Bisceglia, Michelle; Lyons-Weiler, Maureen; Liang, Wenjing; Michalopoulos, George; Becich, Michael; Monzon, Federico A. (2007-04-12). "Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process". BMC Cancer. 7 (1): 64. doi: 10.1186/1471-2407-7-64 . ISSN   1471-2407. PMC   1865555 . PMID   17430594.
  4. 1 2 3 Watanabe, Ryuta; Miura, Noriyoshi; Kurata, Mie; Kitazawa, Riko; Kikugawa, Tadahiko; Saika, Takashi (2023-05-18). "Spatial Gene Expression Analysis Reveals Characteristic Gene Expression Patterns of De Novo Neuroendocrine Prostate Cancer Coexisting with Androgen Receptor Pathway Prostate Cancer". International Journal of Molecular Sciences. 24 (10): 8955. doi: 10.3390/ijms24108955 . ISSN   1422-0067. PMC   10219300 . PMID   37240308.
  5. 1 2 3 GeneCards (Aug 2, 2023). "SERTM2 Gene - Serine Rich And Transmembrane Domain Containing 2" . Retrieved 28 September 2023.
  6. 1 2 3 National Library of Medicine. "Serine rich and transmembrane domain containing 2 (SERTM2) [Homo sapiens (human)], Gene" . Retrieved 28 September 2023.
  7. 1 2 3 Pereira, Isabela T.; Gomes-Júnior, Rubens; Hansel-Frose, Aruana; Liu, Man; Soliman, Hossam A.N.; Chan, Sunny S.K.; Dudley, Samuel C.; Kyba, Michael; Dallagiovanna, Bruno (2024). "Cardiac Development Long Non-Coding RNA (CARDEL) is Activated during Human Heart Development and Contributes to Cardiac Specification and Homeostasis". Cells. 13 (12): 1050. bioRxiv   10.1101/2023.02.19.529122 . doi: 10.3390/cells13121050 . PMID   38920678.
  8. 1 2 "AlphaFold Protein Structure Database". alphafold.ebi.ac.uk. Retrieved 2023-12-14.
  9. 1 2 Jumper, John; Evans, Richard; Pritzel, Alexander; Green, Tim; Figurnov, Michael; Ronneberger, Olaf; Tunyasuvunakool, Kathryn; Bates, Russ; Žídek, Augustin; Potapenko, Anna; Bridgland, Alex; Meyer, Clemens; Kohl, Simon A. A.; Ballard, Andrew J.; Cowie, Andrew (August 2021). "Highly accurate protein structure prediction with AlphaFold". Nature. 596 (7873): 583–589. Bibcode:2021Natur.596..583J. doi:10.1038/s41586-021-03819-2. ISSN   1476-4687. PMC   8371605 . PMID   34265844.
  10. 1 2 Varadi, Mihaly; Anyango, Stephen; Deshpande, Mandar; Nair, Sreenath; Natassia, Cindy; Yordanova, Galabina; Yuan, David; Stroe, Oana; Wood, Gemma; Laydon, Agata; Žídek, Augustin; Green, Tim; Tunyasuvunakool, Kathryn; Petersen, Stig; Jumper, John (2022-01-07). "AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models". Nucleic Acids Research. 50 (D1): D439–D444. doi:10.1093/nar/gkab1061. ISSN   0305-1048. PMC   8728224 . PMID   34791371.
  11. 1 2 "SAPS < Sequence Statistics < EMBL-EBI". www.ebi.ac.uk. Retrieved 2023-12-07.
  12. 1 2 3 4 5 "Home - Gene - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2023-10-23.
  13. 1 2 SERTM2 (SERTM2 - serine rich and transmembrane domain containing 2) [https://www.ncbi.nlm.nih.gov/gene/401613]
  14. Wollscheid Lab (2018). Protter [Computer Software]. https://wlab.ethz.ch/protter/
  15. Lowenthal, Mark S.; Davis, Kiersta S.; Formolo, Trina; Kilpatrick, Lisa E.; Phinney, Karen W. (2016-07-01). "Identification of novel N-glycosylation sites at non-canonical protein consensus motifs". Journal of Proteome Research. 15 (7): 2087–2101. doi:10.1021/acs.jproteome.5b00733. ISSN   1535-3893. PMC   5100817 . PMID   27246700.